Comparison of efficacy of Sodium Valproate versus Levetiracetam in Status Epilepticus
Phase 2
- Conditions
- Health Condition 1: G00-G99- Diseases of the nervous system
- Registration Number
- CTRI/2022/02/040689
- Lead Sponsor
- AIIMS PATNA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a.Any child between age groups, above 1 years and up to 15 years of age presenting to paediatric emergency department with status epilepticus or
admitted in Paediatric department of AIIMS Patna developing status epilepticus.
Exclusion Criteria
a.Child with suspected or proven hepatic dysfunction [sodium valproate is hepatotoxic)
b.Child with known case of inborn error of metabolism
c.Child with known allergy to test drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method